相关实验视频

Updated: Sep 17, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.7K

扩散大B细胞淋巴瘤的特征和预测模型与早期化疗免疫疗法失败

Ying-Yu Dong1, Qing Shi1, Wen Wu1

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in immunology
|July 1, 2025
PubMed
概括

在扩散性大B细胞淋巴瘤中早期发现化疗免疫疗法失败 (ECF) 是至关重要的. 这项研究开发了ECF的预测模型,确定了改善患者结果的关键临床和分子因素.

关键词:
在CAR-T细胞中.DLBCL - 扩散大的B细胞淋巴瘤.这是一种类似于RCHOP的疗法.化疗耐药性 化疗耐药性早期的化疗免疫疗法失败这个名字是名ogramogram.

更多相关视频

Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.1K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.9K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K